文献速递细菌感染、耐药与抗菌药物艾滋病与性传播感染

巴西2015-16年首个全国淋病奈瑟菌抗菌药物敏感性监测

First nationwide antimicrobial susceptibility surveillance for Neisseria gonorrhoeae in Brazil, 2015-16.
PubMed 文献 · J Antimicrob Chemother · 2018-01-01

该研究在巴西五大区域七个哨点收集550株男性尿道分泌物淋球菌,按WHO标准进行质量保证的琼脂稀释法药敏检测。结果显示四环素、环丙沙星、苄青霉素和阿奇霉素耐药率分别为61.6%、55.6%、37.1%和6.9%,所有菌株对头孢曲松和头孢克肟敏感(CLSI折点),但按EUCAST头孢克肟折点有0.2%耐药。

要点

  • 四环素耐药率61.6%(中介34.2%),环丙沙星耐药率55.6%(中介0.5%)。
  • 苄青霉素耐药率37.1%(中介60.4%),阿奇霉素耐药率6.9%(中介8.9%)。
  • 按EUCAST头孢克肟折点,0.2%(n=1)耐药,6.9%(n=38)MIC接近耐药。

核心结论

  • 本研究描述了巴西首个按WHO标准质量保证的淋球菌抗菌药物敏感性全国监测,环丙沙星高耐药促使巴西性传播感染治疗指南修订,阿奇霉素耐药出现和大观霉素敏感性下降需持续监测。

研究设计与样本

  • 研究收集2015至2016年巴西全部五个主要区域(七个哨点)550名男性尿道分泌物淋球菌分离株,采用琼脂稀释法按CLSI建议检测,并按WHO标准进行质量保证。

主要发现

  • 对四环素、环丙沙星、苄青霉素和阿奇霉素的耐药水平(中介敏感性)分别为61.6%(34.2%)、55.6%(0.5%)、37.1%(60.4%)和6.9%(8.9%)。
  • 使用美国CLSI折点,所有分离株对头孢曲松和头孢克肟敏感。
  • 根据欧洲EUCAST头孢克肟折点,0.2%(n=1)的分离株对头孢克肟耐药,6.9%(n=38)的分离株头孢克肟MIC接近耐药。

临床怎么用

  • 环丙沙星高耐药及时促使巴西性传播感染治疗指南进行修订。
  • 作者认为需要持续监测淋球菌抗菌药物敏感性并理想地监测治疗失败,在巴西开具治疗处方时需提高认识。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Gonorrhoea and antimicrobial resistance (AMR) in Neisseria gonorrhoeae are major public health concerns globally. Enhanced AMR surveillance for gonococci is essential worldwide; however, recent quality-assured gonococcal AMR surveillance in Latin America, including Brazil, has been limited. Our aims were to (i) establish the first nationwide gonococcal AMR surveillance, quality assured according to WHO standards, in Brazil, and (ii) describe the antimicrobial susceptibility of clinical gonococcal isolates collected from 2015 to 2016 in all five main regions (seven sentinel sites) of Brazil. METHODS: Gonococcal isolates from 550 men with urethral discharge were examined for susceptibility to ceftriaxone, cefixime, azithromycin, ciprofloxacin, benzylpenicillin and tetracycline using the agar dilution method, according to CLSI recommendations and quality assured according to WHO standards. RESULTS: The levels of resistance (intermediate susceptibility) to tetracycline, ciprofloxacin, benzylpenicillin and azithromycin were 61.6% (34.2%), 55.6% (0.5%), 37.1% (60.4%) and 6.9% (8.9%), respectively. All isolates were susceptible to ceftriaxone and cefixime using the US CLSI breakpoints. However, according to the European EUCAST cefixime breakpoints, 0.2% (n = 1) of isolates were cefixime resistant and 6.9% (n = 38) of isolates had a cefixime MIC bordering on resistance. CONCLUSIONS: This study describes the first national surveillance of gonococcal AMR in Brazil, which was quality assured according to WHO standards. The high resistance to ciprofloxacin (which promptly informed a revision of the Brazilian sexually transmitted infection treatment guideline), emerging resistance to azithromycin and decreasing susceptibility to extended-spectrum cephalosporins necessitate continuous surveillance of gonococcal AMR and ideally treatment failures, and increased awareness when prescribing treatment in Brazil.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Bazzo ML, Golfetto L, Gaspar PC, et al. First nationwide antimicrobial susceptibility surveillance for Neisseria gonorrhoeae in Brazil, 2015-16. J Antimicrob Chemother. 2018. PMID: 29635367. doi:10.1093/jac/dky090

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。